(Q35110261)

6 August 2017

1 reference

title

The natural history of dysplasia and cancer in esophagitis and Barrett esophagus (English)

1 reference

6 August 2017

The Natural History of Dysplasia and Cancer in Esophagitis and Barrett Esophagus (English)

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

25 December 2023

1 reference

Stuart Jon Spechler

1

1 reference

6 August 2017

language of work or name

1 reference

1 May 2003

1 reference

full work available at URL

6 August 2017

http://journals.lww.com/00004836-200305001-00002

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Journal of Clinical Gastroenterology

25 December 2023

published in

1 reference

6 August 2017

volume

36

1 reference

6 August 2017

issue

5 Suppl

1 reference

6 August 2017

page(s)

S2-5; discussion S26-8

1 reference

Clinical practice. Barrett's Esophagus

6 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Hallmarks of cancer progression in Barrett's oesophagus

25 December 2023

2

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

25 December 2023

4

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Epidemiology of columnar-lined esophagus and adenocarcinoma

25 December 2023

5

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease

25 December 2023

6

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

25 December 2023

7

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

25 December 2023

10

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.

25 December 2023

11

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus

25 December 2023

12

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model

25 December 2023

13

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

25 December 2023

14

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

25 December 2023

15

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus

25 December 2023

16

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study

25 December 2023

17

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

25 December 2023

18

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy

25 December 2023

19

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds

25 December 2023

20

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids

25 December 2023

21

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized

25 December 2023

22

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux

25 December 2023

23

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery

25 December 2023

25

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Aspirin and reduced risk of esophageal carcinoma

25 December 2023

26

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

25 December 2023

Disputing dysplasia

29

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

25 December 2023

30

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia

25 December 2023

32

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression

25 December 2023

33

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma

25 December 2023

34

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression

25 December 2023

35

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus

25 December 2023

36

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia

25 December 2023

37

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

Long-term follow-up of Barrett's high-grade dysplasia

25 December 2023

38

1 reference

https://api.crossref.org/works/10.1097/00004836-200305001-00002

25 December 2023

Identifiers

1 reference

6 August 2017

1 reference